Editorial comment: Do AD therapies that delay nursing home placement reduce an MCO's cost?

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)8BH
JournalDrug Benefit Trends
Volume12
Issue number3
StatePublished - Jan 1 2000

Fingerprint

Nursing Homes
Costs and Cost Analysis
Therapeutics
MCO

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this

Editorial comment : Do AD therapies that delay nursing home placement reduce an MCO's cost? / Farlow, M. R.

In: Drug Benefit Trends, Vol. 12, No. 3, 01.01.2000, p. 8BH.

Research output: Contribution to journalComment/debate

@article{b35bdbfd679a47c6b5cdef921c3d2e00,
title = "Editorial comment: Do AD therapies that delay nursing home placement reduce an MCO's cost?",
author = "Farlow, {M. R.}",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
volume = "12",
pages = "8BH",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "3",

}

TY - JOUR

T1 - Editorial comment

T2 - Do AD therapies that delay nursing home placement reduce an MCO's cost?

AU - Farlow, M. R.

PY - 2000/1/1

Y1 - 2000/1/1

UR - http://www.scopus.com/inward/record.url?scp=0034038306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034038306&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:0034038306

VL - 12

SP - 8BH

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - 3

ER -